Assignee
RINUAGENE BIOTECHNOLOGY CO LTD
CN·3 granted patents·4 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
7 records- 0175US12318441B2Polynucleotide molecules used for the prevention or treatment of HPV infection related diseasesRINUAGENE BIOTECHNOLOGY CO LTD·Filed 2024·Granted Jun 3, 2025·0 cites·25 claims
- 0267US12391662B2Lipid compounds and lipid nanoparticle compositionsRINUAGENE BIOTECHNOLOGY CO LTD·Filed 2024·Granted Aug 19, 2025·0 cites·20 claims
- 0364US12312292B2Long chain alkyl esteramine lipid compound, preparation method therefor and application thereof in nucleic acid deliveryRINUAGENE BIOTECHNOLOGY CO LTD·Filed 2023·Granted May 27, 2025·0 cites·3 claims
- 0460US2026028323A1Lipid compounds and lipid nanoparticle compositionsRINUAGENE BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 0558US2025222094A1Polynucleotide molecules used for the prevention or treatment of hpv infection related diseasesRINUAGENE BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 0658US2026092293A1Expression-adjustable engineered rna moleculeRINUAGENE BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 0753US2025215441A1Engineered dna molecule for coding rnaRINUAGENE BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RINUAGENE BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →